ArticlePLoS medicine2025

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).

Stefan Halbherr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.